Basma Adeem Medical Co. vs HCA Healthcare, Inc.
A head-to-head of Basma Adeem Medical Co. (9626) and HCA Healthcare, Inc. (HCA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9626 | HCA |
|---|---|---|
| Market Cap | 118.00M SAR | $82.34B |
| P/E (TTM) | 15.03 | 12.76 |
| Forward P/E | — | 13.11 |
| P/S | 2.60 | 1.26 |
| P/B | 2.61 | -16.19 |
| EV/EBITDA | 9.19 | 9.68 |
| Dividend Yield | — | 0.83% |
| Profit Margin | 16.07% | 8.89% |
| Gross Margin | 29.30% | 41.50% |
| Operating Margin | 17.78% | 15.83% |
| Revenue Growth (YoY) | +44.10% | +4.30% |
| FCF Yield | — | 8.22% |
| Debt / Equity | 30.99 | — |
| Current Ratio | 6.55 | 0.83 |
Which is better: Basma Adeem Medical Co. or HCA Healthcare, Inc.?
- ✓Larger by market cap: HCA Healthcare, Inc.
- ✓Cheaper valuation (lower P/E): HCA Healthcare, Inc.
- ✓More profitable (net margin): Basma Adeem Medical Co.
- ✓Faster revenue growth: Basma Adeem Medical Co.
Across 8 available metrics, Basma Adeem Medical Co. leads 5–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Basma Adeem Medical Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.